Advisor Group Holdings, Inc. Maxcyte, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.63 - $5.0 $519 - $715	-143 Reduced 53.36%	125 $0
Q1 2024 May 10, 2024	SELL	$3.94 - $5.38 $16,654 - $22,741	-4,227 Reduced 94.04%	268 $1,000
Q4 2023 Feb 12, 2024	BUY	$2.6 - $5.24 $1,817 - $3,662	699 Added 18.41%	4,495 $21,000
Q3 2023 Nov 13, 2023	BUY	$3.02 - $5.1 $4,067 - $6,869	1,347 Added 55.0%	3,796 $11,000
Q2 2023 Aug 10, 2023	BUY	$3.69 - $5.35 $4,977 - $7,217	1,349 Added 122.64%	2,449 $11,000
Q1 2022 May 04, 2022	BUY	$5.26 - $10.84 $5,786 - $11,924	1,100 New	1,100 $8,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $426M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.